{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:49:25Z","timestamp":1791326965100,"version":"4.3.1"},"publisher-location":"Totowa, NJ","reference-count":126,"publisher":"Humana Press","isbn-type":[{"value":"9781627034104","type":"print"},{"value":"9781627034111","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-62703-411-1_2","type":"book-chapter","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T13:57:43Z","timestamp":1370872663000},"page":"19-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Huntington\u2019s Disease and Cell Therapies: Past, Present, and Future"],"prefix":"10.1007","author":[{"given":"Chrystalina A.","family":"Antoniades","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,29]]},"reference":[{"issue":"15","key":"2_CR00021","first-page":"317","volume":"26","author":"G Huntington","year":"1872","unstructured":"Huntington G (1872) On Chorea. Med Surg Reporter 26(15):317\u2013321","journal-title":"Med Surg Reporter"},{"key":"2_CR00022","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"issue":"Pt 2","key":"2_CR00023","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/brain\/111.2.223","volume":"111","author":"PD Thompson","year":"1988","unstructured":"Thompson PD, Berardelli A, Rothwell JC et al (1988) The coexistence of bradykinesia and chorea in Huntington\u2019s disease and its implications for theories of basal ganglia control of movement. Brain 111(Pt 2):223\u2013244","journal-title":"Brain"},{"key":"2_CR00024","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1212\/WNL.31.10.1333","volume":"31","author":"I Shoulson","year":"1981","unstructured":"Shoulson I (1981) Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 31:1333\u20131335","journal-title":"Neurology"},{"key":"2_CR00025","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/jnnp.47.8.844","volume":"47","author":"N Quinn","year":"1984","unstructured":"Quinn N, Marsden CD (1984) A double blind trial of sulpiride in Huntington\u2019s disease and tardive dyskinesia. J Neurol Neurosurg Psychiatry 47:844\u2013847","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2_CR00026","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1212\/WNL.35.10.1450","volume":"35","author":"WC Koller","year":"1985","unstructured":"Koller WC, Trimble J (1985) The gait abnormality of Huntington\u2019s disease. Neurology 35:1450\u20131454","journal-title":"Neurology"},{"key":"2_CR00027","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/brain\/awm107","volume":"130","author":"SA Johnson","year":"2007","unstructured":"Johnson SA, Stout JC, Solomon AC et al (2007) Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington\u2019s disease. Brain 130:1732\u20131744","journal-title":"Brain"},{"key":"2_CR00028","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.neuropsychologia.2006.12.015","volume":"45","author":"AC Solomon","year":"2007","unstructured":"Solomon AC, Stout JC, Johnson SA et al (2007) Verbal episodic memory declines prior to diagnosis in Huntington\u2019s disease. Neuropsychologia 45:1767\u20131776","journal-title":"Neuropsychologia"},{"key":"2_CR00029","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/01.WNL.0000098878.47789.BD","volume":"61","author":"AK Ho","year":"2003","unstructured":"Ho AK, Sahakian BJ, Brown RG et al (2003) Profile of cognitive progression in early Huntington\u2019s disease. Neurology 61:1702\u20131706","journal-title":"Neurology"},{"key":"2_CR000210","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jns.2005.07.007","volume":"239","author":"A Peinemann","year":"2005","unstructured":"Peinemann A, Schuller S, Pohl C et al (2005) Executive dysfunction in early stages of Huntington\u2019s disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci 239:11\u201319","journal-title":"J Neurol Sci"},{"key":"2_CR000211","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","volume":"71","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Ready RE, Hamilton JM et al (2001) Neuropsychiatric aspects of Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 71:310\u2013314","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2_CR000212","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/arclin\/4.1.79","volume":"4","author":"S Hall","year":"1989","unstructured":"Hall S, Bigler ED, Rutledge JN (1989) Depression preceding choreiform movements in Huntington\u2019s disease: a case study. Arch Clin Neuropsychol 4:79\u201392","journal-title":"Arch Clin Neuropsychol"},{"key":"2_CR000213","first-page":"193","volume":"1","author":"SE Folstein","year":"1983","unstructured":"Folstein SE, Folstein MF (1983) Psychiatric features of Huntington\u2019s disease: recent approaches and findings. Psychiatr Dev 1:193\u2013205","journal-title":"Psychiatr Dev"},{"key":"2_CR000214","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1176\/appi.neuropsych.17.4.496","volume":"17","author":"JS Paulsen","year":"2005","unstructured":"Paulsen JS, Nehl C, Hoth KF et al (2005) Depression and stages of Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 17:496\u2013502","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2_CR000215","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"RH Myers","year":"2004","unstructured":"Myers RH (2004) Huntington\u2019s disease genetics. NeuroRx 1:255\u2013262","journal-title":"NeuroRx"},{"key":"2_CR000216","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/jnnp.66.1.52","volume":"66","author":"T Foroud","year":"1999","unstructured":"Foroud T, Gray J, Ivashina J et al (1999) Differences in duration of Huntington\u2019s disease based on age at onset. J Neurol Neurosurg Psychiatry 66:52\u201356","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2_CR000217","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella JF, Wexler NS, Conneally PM et al (1983) A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature 306:234\u2013238","journal-title":"Nature"},{"key":"2_CR000218","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle JP et al (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat Genet 4:393\u2013397","journal-title":"Nat Genet"},{"key":"2_CR000219","first-page":"16","volume":"59","author":"DC Rubinsztein","year":"1996","unstructured":"Rubinsztein DC, Leggo J, Coles R et al (1996) Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats. Am J Hum Genet 59:16\u201322","journal-title":"Am J Hum Genet"},{"key":"2_CR000220","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/hmg\/6.5.775","volume":"6","author":"SM McNeil","year":"1997","unstructured":"McNeil SM, Novelletto A, Srinidhi J et al (1997) Reduced penetrance of the Huntington\u2019s disease mutation. Hum Mol Genet 6:775\u2013779","journal-title":"Hum Mol Genet"},{"key":"2_CR000221","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R et al (1993) Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet 4:387\u2013392","journal-title":"Nat Genet"},{"key":"2_CR000222","first-page":"593","volume":"57","author":"NG Ranen","year":"1995","unstructured":"Ranen NG, Stine OC, Abbott MH et al (1995) Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet 57:593\u2013602","journal-title":"Am J Hum Genet"},{"key":"2_CR000223","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1212\/WNL.45.1.143","volume":"45","author":"O Komure","year":"1995","unstructured":"Komure O, Sano A, Nishino N et al (1995) DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation. Neurology 45:143\u2013149","journal-title":"Neurology"},{"key":"2_CR000224","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19:233\u2013238","journal-title":"Trends Genet"},{"key":"2_CR000225","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","volume":"35","author":"BE Lonze","year":"2002","unstructured":"Lonze BE, Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605\u2013623","journal-title":"Neuron"},{"key":"2_CR000226","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","volume":"10","author":"A Wyttenbach","year":"2001","unstructured":"Wyttenbach A, Swartz J, Kita H et al (2001) Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington\u2019s disease. Hum Mol Genet 10:1829\u20131845","journal-title":"Hum Mol Genet"},{"key":"2_CR000227","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D et al (2004) A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet 65:267\u2013277","journal-title":"Clin Genet"},{"key":"2_CR000228","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/jmg.31.11.872","volume":"31","author":"K Kieburtz","year":"1994","unstructured":"Kieburtz K, MacDonald M, Shih C et al (1994) Trinucleotide repeat length and progression of illness in Huntington\u2019s disease. J Med Genet 31:872\u2013874","journal-title":"J Med Genet"},{"key":"2_CR000229","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"2_CR000230","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","volume":"60","author":"HD Rosas","year":"2003","unstructured":"Rosas HD, Koroshetz WJ, Chen YI et al (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615\u20131620","journal-title":"Neurology"},{"key":"2_CR000231","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"2_CR000232","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2990.1997.tb01326.x","volume":"23","author":"V Macdonald","year":"1997","unstructured":"Macdonald V, Halliday GM, Trent RJ et al (1997) Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington\u2019s disease. Neuropathol Appl Neurobiol 23:492\u2013495","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2_CR000233","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/nbdi.2002.0528","volume":"10","author":"V Macdonald","year":"2002","unstructured":"Macdonald V, Halliday G (2002) Pyramidal cell loss in motor cortices in Huntington\u2019s disease. Neurobiol Dis 10:378\u2013386","journal-title":"Neurobiol Dis"},{"key":"2_CR000234","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0304-3940(91)90443-W","volume":"132","author":"HP Kremer","year":"1991","unstructured":"Kremer HP, Roos RA, Dingjan GM et al (1991) The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington\u2019s disease. Neurosci Lett 132:101\u2013104","journal-title":"Neurosci Lett"},{"key":"2_CR000235","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0079-6123(08)64576-8","volume":"93","author":"HP Kremer","year":"1992","unstructured":"Kremer HP (1992) The hypothalamic lateral tuberal nucleus: normal anatomy and changes in neurological diseases. Prog Brain Res 93:249\u2013261","journal-title":"Prog Brain Res"},{"key":"2_CR000236","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1093\/hmg\/11.21.2547","volume":"11","author":"J Modregger","year":"2002","unstructured":"Modregger J, DiProspero NA, Charles V et al (2002) PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington\u2019s disease brains. Hum Mol Genet 11:2547\u20132558","journal-title":"Hum Mol Genet"},{"key":"2_CR000237","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11068-004-0514-8","volume":"33","author":"NA DiProspero","year":"2004","unstructured":"DiProspero NA, Chen EY, Charles V et al (2004) Early changes in Huntington\u2019s disease patient brains involve alterations in cytoskeletal and synaptic elements. J Neurocytol 33:517\u2013533","journal-title":"J Neurocytol"},{"key":"2_CR000238","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.29.1.1","volume":"29","author":"I Shoulson","year":"1979","unstructured":"Shoulson I, Fahn S (1979) Huntington disease: clinical care and evaluation. Neurology 29:1\u20133","journal-title":"Neurology"},{"key":"2_CR000239","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"The Huntington Study Group","year":"1996","unstructured":"The Huntington Study Group (1996) Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 11:136\u2013142","journal-title":"Mov Disord"},{"key":"2_CR000240","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mds.20332","volume":"20","author":"P Hogarth","year":"2005","unstructured":"Hogarth P, Kayson E, Kieburtz K et al (2005) Interrater agreement in the assessment of motor manifestations of Huntington\u2019s disease. Mov Disord 20:293\u2013297","journal-title":"Mov Disord"},{"key":"2_CR000241","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/bmj.2.4897.1121","volume":"2","author":"MJ Pleydell","year":"1954","unstructured":"Pleydell MJ (1954) Huntington\u2019s chorea in Northamptonshire. Br Med J 2:1121\u20131128","journal-title":"Br Med J"},{"key":"2_CR000242","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1136\/bmj.2.4944.889","volume":"2","author":"MJ Pleydell","year":"1955","unstructured":"Pleydell MJ (1955) Huntington\u2019s chorea in Northamptonshire. Br Med J 2:889","journal-title":"Br Med J"},{"key":"2_CR000243","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/bmj.2.5199.650","volume":"2","author":"JJ Reid","year":"1960","unstructured":"Reid JJ (1960) Huntington\u2019s chorea in Northamptonshire. Br Med J 2:650","journal-title":"Br Med J"},{"key":"2_CR000244","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1192\/bjp.116.532.241","volume":"116","author":"JE Oliver","year":"1970","unstructured":"Oliver JE (1970) Huntington\u2019s chorea in North\u00adamptonshire. Br J Psychiatry 116:241\u2013253","journal-title":"Br J Psychiatry"},{"key":"2_CR000245","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/brain\/90.1.203","volume":"90","author":"KW Heathfield","year":"1967","unstructured":"Heathfield KW (1967) Huntington\u2019s chorea. Investigation into the prevalence of this disease in the area covered by the North East Metropolitan Regional Hospital Board. Brain 90:203\u2013232","journal-title":"Brain"},{"key":"2_CR000246","first-page":"41","volume":"27","author":"AJ Caro","year":"1977","unstructured":"Caro AJ (1977) The prevalence of Huntington\u2019s chorea in an area of East Anglia. J R Coll Gen Pract 27:41\u201345","journal-title":"J R Coll Gen Pract"},{"key":"2_CR0002126","first-page":"41","volume":"27","author":"AJ Caro","year":"1977","unstructured":"Critchley, M. (1934). Journal of State Medicine, 42, 575\u2013587","journal-title":"J R Coll Gen Pract"},{"key":"2_CR000247","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1136\/jmg.32.7.524","volume":"32","author":"PJ Morrison","year":"1995","unstructured":"Morrison PJ, Johnston WP, Nevin NC (1995) The epidemiology of Huntington\u2019s disease in Northern Ireland. J Med Genet 32:524\u2013530","journal-title":"J Med Genet"},{"key":"2_CR000248","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"2_CR000249","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5694\/j.1326-5377.1990.tb136828.x","volume":"153","author":"SA Pridmore","year":"1990","unstructured":"Pridmore SA (1990) The prevalence of Huntington\u2019s disease in Tasmania. Med J Aust 153:133\u2013134","journal-title":"Med J Aust"},{"key":"2_CR000250","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1212\/WNL.36.2.244","volume":"36","author":"AB Young","year":"1986","unstructured":"Young AB, Shoulson I, Penney JB et al (1986) Huntington\u2019s disease in Venezuela: neurologic features and functional decline. Neurology 36:244\u2013249","journal-title":"Neurology"},{"key":"2_CR000251","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/FOC\/2008\/24\/3-4\/E8","volume":"24","author":"CD Clelland","year":"2008","unstructured":"Clelland CD, Barker RA, Watts C (2008) Cell therapy in Huntington disease. Neurosurg Focus 24:E9","journal-title":"Neurosurg Focus"},{"key":"2_CR000252","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/3305","volume":"4","author":"PS Eriksson","year":"1998","unstructured":"Eriksson PS, Perfilieva E, Bjork-Eriksson T et al (1998) Neurogenesis in the adult human hippocampus. Nat Med 4:1313\u20131317","journal-title":"Nat Med"},{"key":"2_CR000253","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0092-8674(00)80956-3","volume":"96","author":"CB Johansson","year":"1999","unstructured":"Johansson CB, Momma S, Clarke DL et al (1999) Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96:25\u201334","journal-title":"Cell"},{"key":"2_CR000254","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1523\/JNEUROSCI.22-15-06639.2002","volume":"22","author":"DC Lie","year":"2002","unstructured":"Lie DC, Dziewczapolski G, Willhoite AR et al (2002) The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci 22:6639\u20136649","journal-title":"J Neurosci"},{"key":"2_CR000255","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nm747","volume":"8","author":"A Arvidsson","year":"2002","unstructured":"Arvidsson A, Collin T, Kirik D et al (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8:963\u2013970","journal-title":"Nat Med"},{"key":"2_CR000256","doi-asserted-by":"crossref","first-page":"7768","DOI":"10.1523\/JNEUROSCI.18-19-07768.1998","volume":"18","author":"J Liu","year":"1998","unstructured":"Liu J, Solway K, Messing RO et al (1998) Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci 18:7768\u20137778","journal-title":"J Neurosci"},{"key":"2_CR000257","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bandc.2008.08.017","volume":"68","author":"K Johnston","year":"2008","unstructured":"Johnston K, Everling S (2008) Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates. Brain Cogn 68:271\u2013283","journal-title":"Brain Cogn"},{"key":"2_CR000258","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1523\/JNEUROSCI.22-08-03174.2002","volume":"22","author":"JM Parent","year":"2002","unstructured":"Parent JM, Valentin VV, Lowenstein DH (2002) Prolonged seizures increase proliferating neuroblasts in the adult rat subventricular zone-olfactory bulb pathway. J Neurosci 22:3174\u20133188","journal-title":"J Neurosci"},{"key":"2_CR000259","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"2_CR000260","doi-asserted-by":"publisher","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","volume":"25","author":"W Phillips","year":"2005","unstructured":"Phillips W, Morton AJ, Barker RA (2005) Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease are attributable to the in vivo microenvironment. J Neurosci 25:11564\u201311576","journal-title":"J Neurosci"},{"key":"2_CR000261","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","volume":"15","author":"SE Lazic","year":"2004","unstructured":"Lazic SE, Grote H, Armstrong RJ et al (2004) Decreased hippocampal cell proliferation in R6\/1 Huntington\u2019s mice. Neuroreport 15:811\u2013813","journal-title":"Neuroreport"},{"key":"2_CR000262","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.brainres.2007.04.039","volume":"1155","author":"Z Kohl","year":"2007","unstructured":"Kohl Z, Kandasamy M, Winner B et al (2007) Physical activity fails to rescue hippocampal neurogenesis deficits in the R6\/2 mouse model of Huntington\u2019s disease. Brain Res 1155:24\u201333","journal-title":"Brain Res"},{"key":"2_CR000263","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","volume":"20","author":"JM Gil","year":"2005","unstructured":"Gil JM, Mohapel P, Araujo IM et al (2005) Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington\u2019s disease mice. Neurobiol Dis 20:744\u2013751","journal-title":"Neurobiol Dis"},{"key":"2_CR000264","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.tins.2004.05.013","volume":"27","author":"G Kempermann","year":"2004","unstructured":"Kempermann G, Jessberger S, Steiner B et al (2004) Milestones of neuronal development in the adult hippocampus. Trends Neurosci 27:447\u2013452","journal-title":"Trends Neurosci"},{"key":"2_CR000265","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1242\/dev.015115","volume":"135","author":"C Galichet","year":"2008","unstructured":"Galichet C, Guillemot F, Parras CM (2008) Neurogenin 2 has an essential role in development of the dentate gyrus. Development 135:2031\u20132041","journal-title":"Development"},{"key":"2_CR000266","doi-asserted-by":"publisher","first-page":"e4779","DOI":"10.1371\/journal.pone.0004779","volume":"4","author":"L Roybon","year":"2009","unstructured":"Roybon L, Hjalt T, Stott S et al (2009) Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis. PLoS One 4:e4779","journal-title":"PLoS One"},{"key":"2_CR000267","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","volume":"19","author":"LA Lione","year":"1999","unstructured":"Lione LA, Carter RJ, Hunt MJ et al (1999) Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation. J Neurosci 19:10428\u201310437","journal-title":"J Neurosci"},{"key":"2_CR000268","doi-asserted-by":"publisher","first-page":"e1959","DOI":"10.1371\/journal.pone.0001959","volume":"3","author":"D Dupret","year":"2008","unstructured":"Dupret D, Revest JM, Koehl M et al (2008) Spatial relational memory requires hippocampal adult neurogenesis. PLoS One 3:e1959","journal-title":"PLoS One"},{"key":"2_CR000269","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1126\/science.1173215","volume":"325","author":"CD Clelland","year":"2009","unstructured":"Clelland CD, Choi M, Romberg C et al (2009) A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science 325:210\u2013213","journal-title":"Science"},{"key":"2_CR000270","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/jnnp.58.5.598","volume":"58","author":"KW Lange","year":"1995","unstructured":"Lange KW, Sahakian BJ, Quinn NP et al (1995) Comparison of executive and visuospatial memory function in Huntington\u2019s disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 58:598\u2013606","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2_CR000271","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/jnnp.2004.059253","volume":"76","author":"J Brandt","year":"2005","unstructured":"Brandt J, Shpritz B, Munro CA et al (2005) Differential impairment of spatial location memory in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 76:1516\u20131519","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2_CR000272","doi-asserted-by":"publisher","first-page":"9578","DOI":"10.1073\/pnas.1133382100","volume":"100","author":"E Marcora","year":"2003","unstructured":"Marcora E, Gowan K, Lee JE (2003) Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2. Proc Natl Acad Sci U S A 100:9578\u20139583","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR000273","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuroscience.2010.08.022","volume":"173","author":"V Fedele","year":"2011","unstructured":"Fedele V, Roybon L, Nordstrom U et al (2011) Neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease is impaired at the level of NeuroD1. Neuroscience 173:76\u201381","journal-title":"Neuroscience"},{"key":"2_CR000274","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C et al (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805\u2013809","journal-title":"Science"},{"key":"2_CR000275","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","volume":"22","author":"HE Grote","year":"2005","unstructured":"Grote HE, Bull ND, Howard ML et al (2005) Cognitive disorders and neurogenesis deficits in Huntington\u2019s disease mice are rescued by fluoxetine. Eur J Neurosci 22:2081\u20132088","journal-title":"Eur J Neurosci"},{"key":"2_CR000276","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1023\/A:1012706908779","volume":"24","author":"KB Bjugstad","year":"2001","unstructured":"Bjugstad KB, Zawada WM, Goodman S et al (2001) IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. J Inherit Metab Dis 24:631\u2013647","journal-title":"J Inherit Metab Dis"},{"key":"2_CR000277","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/exnr.1993.1118","volume":"122","author":"D Zhou","year":"1993","unstructured":"Zhou D, DiFiglia M (1993) Basic fibroblast growth factor enhances the growth of postnatal neostriatal GABAergic neurons in vitro. Exp Neurol 122:171\u2013188","journal-title":"Exp Neurol"},{"key":"2_CR000278","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1006\/mcne.1995.1035","volume":"6","author":"TD Palmer","year":"1995","unstructured":"Palmer TD, Ray J, Gage FH (1995) FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol Cell Neurosci 6:474\u2013486","journal-title":"Mol Cell Neurosci"},{"key":"2_CR000279","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/096368970000900507","volume":"9","author":"NS Haque","year":"2000","unstructured":"Haque NS, Isacson O (2000) Neurotrophic factors NGF and FGF-2 alter levels of huntingtin (IT15) in striatal neuronal cell cultures. Cell Transplant 9:623\u2013627","journal-title":"Cell Transplant"},{"key":"2_CR000280","doi-asserted-by":"publisher","first-page":"18189","DOI":"10.1073\/pnas.0506375102","volume":"102","author":"K Jin","year":"2005","unstructured":"Jin K, LaFevre-Bernt M, Sun Y et al (2005) FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington\u2019s disease. Proc Natl Acad Sci U S A 102:18189\u201318194","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR000281","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-2999(83)90150-4","volume":"93","author":"AW Deckel","year":"1983","unstructured":"Deckel AW, Robinson RG, Coyle JT et al (1983) Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington\u2019s disease by day 18 fetal striatal implants. Eur J Pharmacol 93:287\u2013288","journal-title":"Eur J Pharmacol"},{"key":"2_CR000282","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm0698-727","volume":"4","author":"AL Kendall","year":"1998","unstructured":"Kendall AL, Rayment FD, Torres EM et al (1998) Functional integration of striatal allografts in a primate model of Huntington\u2019s disease. Nat Med 4:727\u2013729","journal-title":"Nat Med"},{"key":"2_CR000283","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1046\/j.1460-9568.2002.01959.x","volume":"15","author":"CB Hurelbrink","year":"2002","unstructured":"Hurelbrink CB, Armstrong RJ, Dunnett SB et al (2002) Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS. Eur J Neurosci 15:1255\u20131266","journal-title":"Eur J Neurosci"},{"key":"2_CR000284","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","volume":"356","author":"AC Bachoud-Levi","year":"2000","unstructured":"Bachoud-Levi AC, Remy P, Nguyen JP et al (2000) Motor and cognitive improvements in patients with Huntington\u2019s disease after neural transplantation. Lancet 356:1975\u20131979","journal-title":"Lancet"},{"key":"2_CR000285","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/exnr.1997.6685","volume":"149","author":"OV Kopyov","year":"1998","unstructured":"Kopyov OV, Jacques S, Lieberman A et al (1998) Safety of intrastriatal neurotransplantation for Huntington\u2019s disease patients. Exp Neurol 149:97\u2013108","journal-title":"Exp Neurol"},{"key":"2_CR000286","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0963-6897(97)00028-6","volume":"6","author":"LM Philpott","year":"1997","unstructured":"Philpott LM, Kopyov OV, Lee AJ et al (1997) Neuropsychological functioning following fetal striatal transplantation in Huntington\u2019s chorea: three case presentations. Cell Transplant 6:203\u2013212","journal-title":"Cell Transplant"},{"key":"2_CR000287","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","volume":"73","author":"AE Rosser","year":"2002","unstructured":"Rosser AE, Barker RA, Harrower T et al (2002) Unilateral transplantation of human primary fetal tissue in four patients with Huntington\u2019s disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosurg Psychiatry 73:678\u2013685","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2_CR000288","doi-asserted-by":"publisher","first-page":"12483","DOI":"10.1073\/pnas.0904239106","volume":"106","author":"F Cicchetti","year":"2009","unstructured":"Cicchetti F, Saporta S, Hauser RA et al (2009) Neural transplants in patients with Huntington\u2019s disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci U S A 106:12483\u201312488","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR000289","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","volume":"5","author":"AC Bachoud-Levi","year":"2006","unstructured":"Bachoud-Levi AC, Gaura V, Brugieres P et al (2006) Effect of fetal neural transplants in patients with Huntington\u2019s disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 5:303\u2013309","journal-title":"Lancet Neurol"},{"key":"2_CR000290","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/jnnp.2007.142380","volume":"79","author":"I Reuter","year":"2008","unstructured":"Reuter I, Tai YF, Pavese N et al (2008) Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 79:948\u2013951","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2_CR000291","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1212\/WNL.58.5.687","volume":"58","author":"RA Hauser","year":"2002","unstructured":"Hauser RA, Furtado S, Cimino CR et al (2002) Bilateral human fetal striatal transplantation in Huntington\u2019s disease. Neurology 58:687\u2013695","journal-title":"Neurology"},{"key":"2_CR000292","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","volume":"97","author":"TB Freeman","year":"2000","unstructured":"Freeman TB, Cicchetti F, Hauser RA et al (2000) Transplanted fetal striatum in Huntington\u2019s disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A 97:13877\u201313882","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR000293","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1212\/01.wnl.0000264504.14301.f5","volume":"68","author":"CD Keene","year":"2007","unstructured":"Keene CD, Sonnen JA, Swanson PD et al (2007) Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology 68:2093\u20132098","journal-title":"Neurology"},{"key":"2_CR000294","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/S0140-6736(00)03302-X","volume":"356","author":"O Lindvall","year":"2000","unstructured":"Lindvall O, Bjorklund A (2000) First step towards cell therapy for Huntington\u2019s disease. Lancet 356:1945\u20131946","journal-title":"Lancet"},{"key":"2_CR000295","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2010.08.031","volume":"227","author":"TB Freeman","year":"2011","unstructured":"Freeman TB, Cicchetti F, Bachoud-Levi AC et al (2011) Technical factors that influence neural transplant safety in Huntington\u2019s disease. Exp Neurol 227:1\u20139","journal-title":"Exp Neurol"},{"key":"2_CR000296","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/0306-4522(95)00162-X","volume":"71","author":"P Brundin","year":"1996","unstructured":"Brundin P, Fricker RA, Nakao N (1996) Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington\u2019s disease. Neuroscience 71:895\u2013897","journal-title":"Neuroscience"},{"key":"2_CR000297","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/88158","volume":"19","author":"MA Caldwell","year":"2001","unstructured":"Caldwell MA, He X, Wilkie N et al (2001) Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol 19:475\u2013479","journal-title":"Nat Biotechnol"},{"key":"2_CR000298","doi-asserted-by":"publisher","first-page":"17089","DOI":"10.1073\/pnas.252589099","volume":"99","author":"U Englund","year":"2002","unstructured":"Englund U, Bjorklund A, Wictorin K et al (2002) Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc Natl Acad Sci U S A 99:17089\u201317094","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR000299","doi-asserted-by":"publisher","first-page":"11925","DOI":"10.1523\/JNEUROSCI.1627-07.2007","volume":"27","author":"TR Yamasaki","year":"2007","unstructured":"Yamasaki TR, Blurton-Jones M, Morrissette DA et al (2007) Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci 27:11925\u201311933","journal-title":"J Neurosci"},{"key":"2_CR0002100","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1080\/00207450390207759","volume":"113","author":"L Lescaudron","year":"2003","unstructured":"Lescaudron L, Unni D, Dunbar GL (2003) Autologous adult bone marrow stem cell transplantation in an animal model of huntington\u2019s disease: behavioral and morphological outcomes. Int J Neurosci 113:945\u2013956","journal-title":"Int J Neurosci"},{"key":"2_CR0002101","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1179\/174313208X327955","volume":"30","author":"EM Amin","year":"2008","unstructured":"Amin EM, Reza BA, Morteza BR et al (2008) Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration. Neurol Res 30:1086\u20131090","journal-title":"Neurol Res"},{"key":"2_CR0002102","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1534582306289367","volume":"5","author":"GL Dunbar","year":"2006","unstructured":"Dunbar GL, Sandstrom MI, Rossignol J et al (2006) Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington\u2019s disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells. Behav Cogn Neurosci Rev 5:63\u201379","journal-title":"Behav Cogn Neurosci Rev"},{"key":"2_CR0002103","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.mcn.2007.11.001","volume":"37","author":"K Bantubungi","year":"2008","unstructured":"Bantubungi K, Blum D, Cuvelier L et al (2008) Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington\u2019s disease. Mol Cell Neurosci 37:454\u2013470","journal-title":"Mol Cell Neurosci"},{"key":"2_CR0002104","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF03033174","volume":"5","author":"AI Rodriguez","year":"2003","unstructured":"Rodriguez AI, Willing AE, Saporta S et al (2003) Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington\u2019s disease: a preliminary study. Neurotox Res 5:443\u2013450","journal-title":"Neurotox Res"},{"key":"2_CR0002105","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.biomaterials.2009.11.084","volume":"31","author":"GJ Delcroix","year":"2010","unstructured":"Delcroix GJ, Schiller PC, Benoit JP et al (2010) Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials 31:2105\u20132120","journal-title":"Biomaterials"},{"key":"2_CR0002106","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2007.05.066","volume":"423","author":"J Song","year":"2007","unstructured":"Song J, Lee ST, Kang W et al (2007) Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions. Neurosci Lett 423:58\u201361","journal-title":"Neurosci Lett"},{"key":"2_CR0002107","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1634\/stemcells.2005-0413","volume":"24","author":"M Dihne","year":"2006","unstructured":"Dihne M, Bernreuther C, Hagel C et al (2006) Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain. Stem Cells 24:1458\u20131466","journal-title":"Stem Cells"},{"key":"2_CR0002108","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-7091-0641-9_1","volume":"28","author":"T Ostenfeld","year":"2003","unstructured":"Ostenfeld T, Svendsen CN (2003) Recent advances in stem cell neurobiology. Adv Tech Stand Neurosurg 28:3\u201389","journal-title":"Adv Tech Stand Neurosurg"},{"key":"2_CR0002109","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0014-4886(03)00037-2","volume":"181","author":"P Lu","year":"2003","unstructured":"Lu P, Jones LL, Snyder EY et al (2003) Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181:115\u2013129","journal-title":"Exp Neurol"},{"key":"2_CR0002110","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/dbio.1994.1250","volume":"165","author":"K Mizuno","year":"1994","unstructured":"Mizuno K, Carnahan J, Nawa H (1994) Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol 165:243\u2013256","journal-title":"Dev Biol"},{"key":"2_CR0002111","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1385\/JMN:17:1:25","volume":"17","author":"F Ciccolini","year":"2001","unstructured":"Ciccolini F, Svendsen CN (2001) Neurotrophin responsiveness is differentially regulated in neurons and precursors isolated from the developing striatum. J Mol Neurosci 17:25\u201333","journal-title":"J Mol Neurosci"},{"key":"2_CR0002112","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0165-3806(96)83489-4","volume":"90","author":"N Nakao","year":"1995","unstructured":"Nakao N, Brundin P, Funa K et al (1995) Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Res Dev Brain Res 90:92\u2013101","journal-title":"Brain Res Dev Brain Res"},{"key":"2_CR0002113","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","volume":"27","author":"AD Strand","year":"2007","unstructured":"Strand AD, Baquet ZC, Aragaki AK et al (2007) Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27:11758\u201311768","journal-title":"J Neurosci"},{"key":"2_CR0002114","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","volume":"24","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Varshney NK et al (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism. J Neurosci 24:2270\u20132276","journal-title":"J Neurosci"},{"key":"2_CR0002115","doi-asserted-by":"publisher","first-page":"7346","DOI":"10.1073\/pnas.93.14.7346","volume":"93","author":"KD Anderson","year":"1996","unstructured":"Anderson KD, Panayotatos N, Corcoran TL et al (1996) Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proc Natl Acad Sci U S A 93:7346\u20137351","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR0002116","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1523\/JNEUROSCI.16-16-05168.1996","volume":"16","author":"DF Emerich","year":"1996","unstructured":"Emerich DF, Lindner MD, Winn SR et al (1996) Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington\u2019s disease. J Neurosci 16:5168\u20135181","journal-title":"J Neurosci"},{"key":"2_CR0002117","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3727\/000000004783983981","volume":"13","author":"DF Emerich","year":"2004","unstructured":"Emerich DF, Winn SR (2004) Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington\u2019s disease are dependent on the proximity of the implant to the lesioned striatum. Cell Transplant 13:253\u2013259","journal-title":"Cell Transplant"},{"key":"2_CR0002118","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1089\/10430340050015220","volume":"11","author":"V Mittoux","year":"2000","unstructured":"Mittoux V, Joseph JM, Conde F et al (2000) Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington\u2019s disease. Hum Gene Ther 11:1177\u20131187","journal-title":"Hum Gene Ther"},{"key":"2_CR0002119","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/exnr.2001.7859","volume":"174","author":"S Marco","year":"2002","unstructured":"Marco S, Canudas AM, Canals JM et al (2002) Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum. Exp Neurol 174:243\u2013252","journal-title":"Exp Neurol"},{"key":"2_CR0002120","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1046\/j.1471-4159.2001.00538.x","volume":"78","author":"E Gratacos","year":"2001","unstructured":"Gratacos E, Perez-Navarro E, Tolosa E et al (2001) Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J Neurochem 78:1287\u20131296","journal-title":"J Neurochem"},{"key":"2_CR0002121","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0014-4886(03)00044-X","volume":"181","author":"JL McBride","year":"2003","unstructured":"McBride JL, During MJ, Wuu J et al (2003) Structural and functional neuroprotection in a rat model of Huntington\u2019s disease by viral gene transfer of GDNF. Exp Neurol 181:213\u2013223","journal-title":"Exp Neurol"},{"key":"2_CR0002122","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cne.20176","volume":"475","author":"JL McBride","year":"2004","unstructured":"McBride JL, Behrstock SP, Chen EY et al (2004) Human neural stem cell transplants improve motor function in a rat model of Huntington\u2019s disease. J Comp Neurol 475:211\u2013219","journal-title":"J Comp Neurol"},{"key":"2_CR0002123","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.0508875103","volume":"103","author":"JL McBride","year":"2006","unstructured":"McBride JL, Ramaswamy S, Gasmi M et al (2006) Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington\u2019s disease. Proc Natl Acad Sci USA 103:9345\u20139350","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR0002124","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/brain\/awq328","volume":"134","author":"F Cicchetti","year":"2011","unstructured":"Cicchetti F, Soulet D, Freeman TB (2011) Neuronal degeneration in striatal transplants and Huntington\u2019s disease: potential mechanisms and clinical implications. Brain 134:641\u2013652","journal-title":"Brain"},{"key":"2_CR0002125","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","volume":"361","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E (2009) A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease. N Engl J Med 361:1268\u20131278","journal-title":"N Engl J Med"}],"container-title":["Methods in Molecular Biology","Trinucleotide Repeat Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-411-1_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T13:24:59Z","timestamp":1676813099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-411-1_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9781627034104","9781627034111"],"references-count":126,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-411-1_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"29 March 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}